| Disclosure of details of non-current financial assets |
Detail of financial instruments included in the statements of financial position and impact on income | | | | | | | | | | | | | | | | As of December 31, 2025 | | (in thousands of euros) | Book value on the statement of financial position | Financial assets carried at fair value through profit or loss | Assets and liabilities carried at amortized cost | Fair value (1) | | Non-current financial assets | | | | | | Non-current financial assets | 434 | | — | | 434 | | 434 | | | Trade receivables | 2,136 | | — | | 2,136 | | 2,136 | | | Cash and cash equivalents | 52,750 | | — | | 52,750 | | 52,750 | | | Total assets | 55,320 | | — | | 55,320 | | 55,320 | | | Financial liabilities | | | | | | Non-current financial liabilities | 91,010 | | — | | 91,010 | | 94,282 | | | Current financial liabilities | 4,309 | | — | | 4,309 | | 4,358 | | | Trade payables and other payables | 9,121 | | — | | 9,121 | | 9,121 | | | Total liabilities | 104,441 | | — | | 104,441 | | 107,760 | |
(1)The fair value of current and non-current liabilities include loans, repayable advances from Bpifrance, the EIB loan, the HCR royalty financing and the HSBC and Bpifrance state-guaranteed loans, was assessed using unobservable “level 3” inputs, in the IFRS 13 classification for fair value. See Note 13 - Financial liabilities. | | | | | | | | | | | | | | | | As of December 31, 2024 | | (in thousands of euros) | Book value on the statement of financial position | Financial assets carried at fair value through profit or loss | Assets and liabilities carried at amortized cost | Fair value (1) | | Non-current financial assets | | | | | | Non-current financial assets | 406 | | — | | 406 | | 406 | | | Trade receivables | 2,977 | | — | | 2,977 | | 2,977 | | | Cash and cash equivalents | 49,737 | | — | | 49,737 | | 49,737 | | | Total assets | 53,120 | | — | | 53,120 | | 53,120 | | | Financial liabilities | | | | | | Non-current financial liabilities | 45,978 | | — | | 45,978 | | 48,443 | | | Current financial liabilities | 4,924 | | — | | 4,924 | | 4,924 | | | Trade payables and other payables | 20,035 | | — | | 20,035 | | 20,035 | | | Total liabilities | 70,936 | | — | | 70,936 | | 73,402 | |
(1)The fair value of current and non-current liabilities include loans, repayable advances from Bpifrance, the EIB loan and the HSBC and Bpifrance state-guaranteed loans, was assessed using unobservable “level 3” inputs, in the IFRS 13 classification for fair value. See Note 13 - Financial liabilities.
|
| Disclosure of details of financial liabilities |
| | | | | | | | | | | As of December 31, | | (in thousands of euros) | 2025 | 2024 | | | Lease liabilities – Short term | 1,210 | | 1,261 | | | | Repayable BPI loan advances - Short term | 804 | | 689 | | | | PGE Loans* | 1,571 | | 2,543 | | | | EIB Loan – Short term | 725 | | 430 | | | Royalty Financing - Short term | — | | — | | | | Total current financial liabilities | 4,309 | | 4,924 | | | | Lease liabilities – Long term | 1,889 | | 2,969 | | | | Repayable BPI loan advances – Long term | 136 | | 1,258 | | | | PGE Loans* | — | | 1,547 | | | | EIB loan – Long term | 47,717 | | 40,204 | | | Royalty Financing - Long term | 41,269 | | — | | | | Total non-current financial liabilities | 91,010 | | 45,978 | | | | Total financial liabilities | 95,320 | | 50,902 | | |
(*)”PGE”or in French “Prêts garantis par l’Etat” are state-guaranteed loans Detail of financial instruments included in the statements of financial position and impact on income | | | | | | | | | | | | | | | | As of December 31, 2025 | | (in thousands of euros) | Book value on the statement of financial position | Financial assets carried at fair value through profit or loss | Assets and liabilities carried at amortized cost | Fair value (1) | | Non-current financial assets | | | | | | Non-current financial assets | 434 | | — | | 434 | | 434 | | | Trade receivables | 2,136 | | — | | 2,136 | | 2,136 | | | Cash and cash equivalents | 52,750 | | — | | 52,750 | | 52,750 | | | Total assets | 55,320 | | — | | 55,320 | | 55,320 | | | Financial liabilities | | | | | | Non-current financial liabilities | 91,010 | | — | | 91,010 | | 94,282 | | | Current financial liabilities | 4,309 | | — | | 4,309 | | 4,358 | | | Trade payables and other payables | 9,121 | | — | | 9,121 | | 9,121 | | | Total liabilities | 104,441 | | — | | 104,441 | | 107,760 | |
(1)The fair value of current and non-current liabilities include loans, repayable advances from Bpifrance, the EIB loan, the HCR royalty financing and the HSBC and Bpifrance state-guaranteed loans, was assessed using unobservable “level 3” inputs, in the IFRS 13 classification for fair value. See Note 13 - Financial liabilities. | | | | | | | | | | | | | | | | As of December 31, 2024 | | (in thousands of euros) | Book value on the statement of financial position | Financial assets carried at fair value through profit or loss | Assets and liabilities carried at amortized cost | Fair value (1) | | Non-current financial assets | | | | | | Non-current financial assets | 406 | | — | | 406 | | 406 | | | Trade receivables | 2,977 | | — | | 2,977 | | 2,977 | | | Cash and cash equivalents | 49,737 | | — | | 49,737 | | 49,737 | | | Total assets | 53,120 | | — | | 53,120 | | 53,120 | | | Financial liabilities | | | | | | Non-current financial liabilities | 45,978 | | — | | 45,978 | | 48,443 | | | Current financial liabilities | 4,924 | | — | | 4,924 | | 4,924 | | | Trade payables and other payables | 20,035 | | — | | 20,035 | | 20,035 | | | Total liabilities | 70,936 | | — | | 70,936 | | 73,402 | |
(1)The fair value of current and non-current liabilities include loans, repayable advances from Bpifrance, the EIB loan and the HSBC and Bpifrance state-guaranteed loans, was assessed using unobservable “level 3” inputs, in the IFRS 13 classification for fair value. See Note 13 - Financial liabilities.
|
| Disclosure of effect of changes in exchange rates |
| | | | | | | | | | | | | | | | For the year ended December 31, 2025 | | Impact | Royalty Financing | Cash and Cash equivalents | | (in thousands of euros) | Increase | Decrease | Increase | Decrease | | USD / Euro exchange rate | 4,127 | | (4,127) | | 3,237 | | (3,237) | | | Total | 4,127 | | (4,127) | | 3,237 | | (3,237) | |
| | | | | | | | | | | | | | | | For the year ended December 31, 2024 | | Impact | Royalty Financing | Cash and Cash equivalents | | (in thousands of euros) | Increase | Decrease | Increase | Decrease | | USD / Euro exchange rate | — | | — | | 4,199 | | (4,199) | | | Total | — | | — | | 4,199 | | (4,199) | |
The following table shows the impact of a 10% increase or decrease in the exchange rate between the euro and the U.S. dollar, calculated on the amounts of loans to the Company’s U.S. subsidiaries as of December 31, 2025 and December 31, 2024. | | | | | | | | | | | | | | | | | | | For the year ended December 31, 2025 | | Impact | Net income | | Equity | | (in thousands of euros) | Increase | Decrease | | Increase | Decrease | | USD / Euro exchange rate | (11) | | 11 | | | 20 | | (20) | | | Total | (11) | | 11 | | | 20 | | (20) | |
| | | | | | | | | | | | | | | | | | | For the year ended December 31, 2024 | | Impact | Net income | | Equity | | (in thousands of euros) | Increase | Decrease | | Increase | Decrease | | USD / Euro exchange rate | 56 | | (56) | | | 35 | | (35) | | | Total | 56 | | (56) | | | 35 | | (35) | |
|